Search clinical trials for: carfilzomib, lenalidomide plus dexamethasone
Total 539 results
-
McGill University Health Centre/Research Institute...RecruitingLeft Ventricular HypertrophyCanada
-
University College, LondonCompleted
-
Criterium, Inc.AmgenCompleted
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford HospitalActive, not recruiting
-
Poitiers University HospitalSanofi; Intergroupe Francophone du MyelomeActive, not recruiting
-
CelgeneCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; Millennium Pharmaceuticals... and other collaboratorsCompleted
-
University Magna GraeciaCompletedPolycystic Ovary Syndrome | AnovulationItaly
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
PfizerCompletedAdvanced Multiple MyelomaUnited States
-
Menoufia UniversityCompleted
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Japan, Canada, Netherlands, Denmark, Sweden, Korea, Republic of, Russian Federation, Greece
-
CelgeneCompleted
-
National Cancer Institute (NCI)Millennium Pharmaceuticals, Inc.Withdrawn
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
European Myeloma NetworkEMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Greece, Italy
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
Mayo ClinicActive, not recruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Smoldering Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasmacytoma | POEMS SyndromeUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR); Myeloma CanadaRecruiting
-
Starton Therapeutics, IncRecruitingMultiple MyelomaUnited States
-
PfizerRecruitingMultiple MyelomaJapan, Taiwan, Canada, Spain, Australia, Italy, Czechia, Korea, Republic of, France, Greece, Israel, Poland, Germany
-
Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, Australia, Spain, France, Poland
-
Karyopharm Therapeutics IncWithdrawn
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
UNC Lineberger Comprehensive Cancer CenterGenzyme, a Sanofi CompanyRecruitingCancer | Multiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieNo longer available
-
Janssen Research & Development, LLCCompleted
-
University College, LondonCancer Research UK; CelgeneActive, not recruitingPlasmacytomaUnited Kingdom
-
CelgeneCompleted
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
PETHEMA FoundationBristol-Myers Squibb; Sanofi; Adknoma; Start from scratchNot yet recruitingNewly Diagnosed Multiple MyelomaSpain
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Keymed Biosciences Co.LtdRecruitingLymphoma | Multiple MyelomaChina
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Affiliated Hospital of Nantong UniversityRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | ISS Stage III Plasma Cell MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); AmgenActive, not recruitingPlasma Cell MyelomaUnited States
-
Zagazig UniversityActive, not recruitingPostoperative PainEgypt
-
Retinal Consultants of ArizonaAllerganCompletedDiabetes Mellitus | Macular EdemaUnited States
-
Huashan HospitalRecruitingChronic Subdural HematomaChina
-
Amsterdam UMC, location VUmcCelgeneActive, not recruitingMultiple MyelomaNetherlands
-
University of LuebeckCompleted
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingMultiple Myeloma | Newly Diagnosed Multiple Myeloma | Autologous Stem Cell TransplantationUnited States